Stereotaktische strahlentherapie am adaptierten linearbeschleuniger bei patienten mit hirnmetastasen

Translated title of the contribution: Stereotactic radiotherapy using linear accelerator in patients with brain metastases

A. L. Grosu, H. J. Feldmann, S. Stärk, M. Pinsker, C. Nieder, P. Kneschaurek, C. Lumenta, M. Molls

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The aim of the study was to analyze the results of stereotactic radiotherapy using a linear accelerator in patients with brain metastases. We quantified the following clinical parameters: tumor response and tumor control after therapy, survival, and side effects. Results of the treatment were compared with those from traditional treatment strategies such as surgery and whole brain irradiation. Sixty patients with brain metastases (80 lesions, 36 men and 24 women, mean age 57 years) were treated with stereotactic radiotherapy. The mean follow-up time was 13 months. Conclusion: Stereotactic radiotherapy is an important option in the treatment strategy for patients with brain metastases. In comparison to whole brain irradiation, stereotactic radiotherapy achieved a higher local tumor control with a lower rate of side effects. In comparison to surgery, stereotactic radiotherapy has the advantages of shorter treatment time and lower treatment-related morbidity and mortality.

Translated title of the contributionStereotactic radiotherapy using linear accelerator in patients with brain metastases
Original languageGerman
Pages (from-to)770-781
Number of pages12
JournalNervenarzt
Volume72
Issue number10
DOIs
StatePublished - 2001

Fingerprint

Dive into the research topics of 'Stereotactic radiotherapy using linear accelerator in patients with brain metastases'. Together they form a unique fingerprint.

Cite this